JERUSALEM, Jan. 26, 2015 /PRNewswire/ -- NovellusDx, the leading Precision Cancer Analysis™ company delivering actionable intelligence about the mutational hierarchies that drive each patient's cancer progression, announced today that the company will highlight data from...